Research recommendation(s) from an individual piece of guidance
|Guidance||Myocardial infarction: cardiac rehabilitation and prevention of further cardiovascular disease|
|Date issued||November 2013|
Research recommendations coming out of this guidance
- In people who have not undergone revascularisation after an MI, does clopidogrel and placebo have a better outcome than clopidogrel and aspirin?
- Does continuing beta-blocker treatment beyond 1 year after an MI improve outcomes for people with normal left ventricular systolic function?
Is treatment with an oral anticoagulant, aspirin and clopidogrel preferable to treatment with an oral
anticoagulant and clopidogrel in people who have had an MI, have an indication for oral anticoagulation and are treated either medically, by primary PCI or by coronary artery bypass grafting surgery?
- What characteristics are associated with uptake and adherence to cardiac rehabilitation after an acute MI when rehabilitation is started early?
- In people who have had a STEMI who undergo primary PCI with a bare-metal stent, and 4 weeks of aspirin and clopidogrel, is there an additional benefit to continuing clopidogrel for a further 11 months?